0.50 / AMA PRA Category 1 Credit(s)TM 0.50 / CNE for Nurses
This activity is provided by Haymarket Medical Education (HME) for physician credit. This activity is jointly provided by Global Education Group and HME for nursing contact hours.
Supported by Ironwood Pharmaceuticals, Inc.
At the present time, gout is treated suboptimally. Poor disease control with recurrent flares and frequent hospitalizations are common. In addition, only 30% of patients who are candidates for urate-lowering therapy actually receive it. Updated guidelines recently published by the American College of Physicians (ACP) directly contradict the “treat-to-target” focus on controlling serum uric acid levels that is recommended by the American College of Rheumatology (ACR) and the European League against Rheumatism (EULAR). As a result, clinicians may be uncertain as to why and how to treat underlying hyperuricemia in patients with gout.
In this educational activity, 2 gout clinical experts review key pearls from evidence-based guidelines for gout management, including those from the ACP, ACR, and EULAR. Key differences among the various recommendations relative to the long-term management of hyperuricemia will be discussed in detail, and the implications for clinical practice will be reviewed.
Primary care and internal medicine clinicians (MDs/DOs, physician assistants [PAs], nurse practitioners [NPs], and nurses); rheumatologists
After completing the activity, the participant should be better able to:
Describe the rationale for addressing underlying hyperuricemia in patients with gout
Review key differences in evidence-based guidelines for gout management disseminated by leading national medical organizations
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, HME and Global Education Group require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and Global Education resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
Robert Terkeltaub, MD Professor of Medicine Division of Rheumatology and Immunology University of California San Diego San Diego, CA
Dr. Terkeltaub receives consulting fees from Horizon Pharma, Innovations Consulting Group, Relburn-Metabolomics, and Selecta Biosciences, and conducts contracted research for Ardea Biosciences.
Arthur Weaver, MD, MS, FACP, MACR Clinical Professor of Medicine Emeritus Department of Medicine Section of Rheumatology University of Nebraska Medical Center Omaha, NE
Dr. Weaver is a consultant to Horizon Pharma, has received honoraria from Takeda Pharmaceuticals North America, and is on the speaker’s bureau for Amgen.
Accredited Provider Disclosures
The planners, managers, and reviewers for this program reported the following financial relationships with commercial interests whose products or services may be related to the content of this CME activity:
HME planners, managers, and reviewers have no relevant financial relationships to disclose. Global Education Group planners: Ashley Marostica, RN, MSN, Lindsay Borvansky, and Liddy Knight have nothing to disclose.
Publishing Staff Disclosures
Susan Basilico and Krista Sierra have nothing to disclose in regard to commercial support.
AMA PRA Category 1 Credit(s)TM
Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Haymarket Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Contact Hour(s)
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 0.50 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity. This activity is jointly provided by Global Education Group and Haymarket for ANCC credit.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. HME and Global Education Group do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Ironwood, Global Education Group, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
In order to receive credit for this activity, the participant must complete the pre-activity questionnaire, post-test, and program evaluation. Participants must also score at least 70% on the post-test. Certificates will be distributed online at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.